Beta Booster
MirZyme Therapeutics Selected as Member of ARPA-H InvestorCatalyst Hub Spoke Network
MirZyme announced today that it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health...
top of page
Search
Beta Booster
- Mar 15
- 1 min
MirZyme Therapeutics granted a new US patent
The MirZyme Therapeutics team are delighted to announce that we have been granted a new US patent to predict and prevent pregnancy...
66 views0 comments
Beta Booster
- Mar 1
- 1 min
CEO Professor Asif Ahmed PhD FRSB receives the “Health Innovation & Excellence Award” from the Maternal Aid Association
“Talent is rare but rarer is grit”. We are proud to share with you the news that our founder and CEO Professor Asif Ahmed PhD FRSB...
28 views0 comments
Beta Booster
- Feb 15
- 1 min
Health Innovation & Excellence Award
Professor Asif Ahmed is deeply honoured and humbled to receive this award from Maternal Aids Association for our groundbreaking work in...
103 views0 comments
Beta Booster
- Feb 9
- 1 min
Professor Asif Ahmed has been awarded the ‘Health Innovation & Excellence’
We’re thrilled to announce that Professor Asif Ahmed, our founder and Executive Chairman, has been awarded the ‘Health Innovation &...
14 views0 comments
Beta Booster
- Dec 13, 2023
- 2 min
Lord Oxmantown Joins MirZyme as Global Ambassador to help make preeclampsia history!
MirZyme, a leading UK-based FemTech dedicated to addressing pregnancy complications, proudly announces the appointment of Lord Oxmantown...
35 views0 comments
Beta Booster
- Sep 16, 2023
- 1 min
MirZyme win the Lee Kuan Yew Global Business Plan Completion prize
Team MirZyme have won the Lee Kuan Yew Global Business Plan Completion prize entitled: 'Best Professor-Student Team’, having been invited...
15 views0 comments
Aadil Qayium
- May 14, 2023
- 2 min
Concept Foundation and MirZyme Therapeutics to partner to help prevent preeclampsia across the world
Geneva, April 2023. The partnership between Concept Foundation and MirZyme is a critical step toward in the prevention and treatment of...
66 views0 comments
Aadil Qayium
- May 14, 2023
- 4 min
MIRZYME AWARDED THE FIRST FAST-TRACK INNOVATION PASSPORT FOR THE TREATMENT OF PREECLAMPSIA
MIRZYME THERAPEUTICS AWARDED THE FIRST FAST-TRACK INNOVATION PASSPORT FOR THE TREATMENT OF PREECLAMPSIA FROM THE MHRA, THE UK REGULATOR...
83 views0 comments
Aadil Qayium
- May 14, 2023
- 2 min
CEO Nominated for Businessman of The Year
CEO of Mirzyme Professor Asif Ahmed (www.asifahmed.org) has been nominated for Birmingham Buisnessman Of The Year 2022. He is a...
29 views0 comments
Aadil Qayium
- May 14, 2023
- 1 min
Women’s Health Innovation Summit - Boston, USA
Mirzyme has been selected as a finalist for the Women's Health Innovation Showcase USA. Out of 125 companies, Mirzyme is one of 24 to be...
10 views0 comments
Aadil Qayium
- May 14, 2023
- 2 min
U.K. policy report sets out a vision to incentivise industry to develop pregnancy-specific medicines
The United Kingdom published its first policy commission report on maternal drug development. The report was launched in the House of...
26 views0 comments
Aadil Qayium
- May 14, 2023
- 1 min
ONE PILL WONDER – MirZyme Therapeutics on AIMDay at Oxford University
The Nuffield Department of Women’s & Reproductive Health at the University of Oxford hosted an Academic-Industry Meeting Day (AIMday) in...
14 views0 comments
Aadil Qayium
- May 14, 2023
- 1 min
Women's Health Strategy: Call for Evidence
The UK government asked the views of organisations, experts and individuals to help inform the development of the government’s Women’s...
4 views0 comments
Aadil Qayium
- May 14, 2023
- 3 min
COVID-19 leads to preeclampsia and poor pregnancy outcomes
Birmingham, June 2021 A peer-reviewed article in the prestigious British Journal of Pharmacology “The Impact of COVID-19 on Pregnancy and...
5 views0 comments
Aadil Qayium
- May 14, 2023
- 1 min
Saving the Lives of Mothers and Babies - Webinar
The month of May is Preeclampsia Awareness Month. Through a series of webinars, discussions and workshops, MirZyme is raising awareness...
9 views0 comments
Aadil Qayium
- May 14, 2023
- 3 min
Two breakthrough studies show a hydrogen sulfide drug prevents preeclampsia
Preeclampsia is a life-threatening pregnancy disorder affecting one in twelve of 130 million annual pregnancies worldwide and causes the...
142 views0 comments
Aadil Qayium
- May 14, 2023
- 3 min
MirZyme Therapeutics partners with King Abdulaziz University
MirZyme Therapeutics partners with King Abdulaziz University to accelerate the development of targeted therapeutics using artificial...
15 views0 comments
Aadil Qayium
- May 14, 2023
- 3 min
Scientists at MirZyme have developed a breakthrough ‘miracle’ cure for preeclampsia
PRESS RELEASE Scientists at MirZyme Therapeutics have discovered a cure for preeclampsia, a life- threatening hypertensive disorder...
62 views0 comments
Aadil Qayium
- May 14, 2023
- 1 min
Europe’s New Roadmap for a Healthier Pregnancy
The death of Lady Sybil during childbirth in the BBC period drama ‘Downton Abbey’ highlighted the risky business of pregnancy caused by...
5 views0 comments
bottom of page